“…For example, floating lipid beads showed better oral bioavailability (162.7%) of Cinnarizine as compared to non-floatable Stugeron ® 34. In addition, Ofloxacin-loaded floating hollow microcapsules exhibited a higher oral bioavailability (124.1%) as compared to commercial Ofloxacin tablets 35. The buoyancy of the PLGA microcapsules and PLGA/PCL microcapsules is plotted in Figure 5.…”
The World Health Organization (WHO) has reported that globally 235 million people suffer from chronic and other inflammatory diseases. The short half-lives of nonsteroidal anti-inflammatory drugs (NSAIDs) and their notoriety in causing gastrointestinal discomforts, warrants these drugs to be released in a controlled and sustained manner. Although polymeric particles have been widely used for drug delivery, there are few reports that showcase their ability in encapsulating and sustaining the release of NSAIDs. In this paper, polymeric nanoencapsulating microcapsules loaded with NSAIDs were fabricated using solid/water/oil/water emulsion solvent evaporation method. Two NSAIDs, ibuprofen and naproxen, were first pre-loaded into nanoparticles and then encapsulated into a larger hollow microcapsule that contained the third NSAID, celecoxib. A high encapsulation efficiency (%) of these NSAIDs was achieved and a sustained release (up to 30 days) of these drugs in phosphate-buffered saline was observed. Then, a gastrointestinal drug – cimetidine (CIM) – was co-loaded with the NSAIDs. This floating delivery system exhibited excellent buoyancy (~88% up to 24 h) in simulated gastric fluid. It also allowed a sequential release of the drugs, whereby an immediate release of CIM followed by NSAIDs was observed. Drug release of the NSAIDs observed Fickian diffusion mechanism, whereas CIM observed non-Fickian diffusion. Therefore, this delivery system is a promising platform to control the delivery of NSAIDs to combat inflammatory diseases, thereby protecting against possible gastrointestinal side effects that may arise from the overuse of NSAIDs.
“…For example, floating lipid beads showed better oral bioavailability (162.7%) of Cinnarizine as compared to non-floatable Stugeron ® 34. In addition, Ofloxacin-loaded floating hollow microcapsules exhibited a higher oral bioavailability (124.1%) as compared to commercial Ofloxacin tablets 35. The buoyancy of the PLGA microcapsules and PLGA/PCL microcapsules is plotted in Figure 5.…”
The World Health Organization (WHO) has reported that globally 235 million people suffer from chronic and other inflammatory diseases. The short half-lives of nonsteroidal anti-inflammatory drugs (NSAIDs) and their notoriety in causing gastrointestinal discomforts, warrants these drugs to be released in a controlled and sustained manner. Although polymeric particles have been widely used for drug delivery, there are few reports that showcase their ability in encapsulating and sustaining the release of NSAIDs. In this paper, polymeric nanoencapsulating microcapsules loaded with NSAIDs were fabricated using solid/water/oil/water emulsion solvent evaporation method. Two NSAIDs, ibuprofen and naproxen, were first pre-loaded into nanoparticles and then encapsulated into a larger hollow microcapsule that contained the third NSAID, celecoxib. A high encapsulation efficiency (%) of these NSAIDs was achieved and a sustained release (up to 30 days) of these drugs in phosphate-buffered saline was observed. Then, a gastrointestinal drug – cimetidine (CIM) – was co-loaded with the NSAIDs. This floating delivery system exhibited excellent buoyancy (~88% up to 24 h) in simulated gastric fluid. It also allowed a sequential release of the drugs, whereby an immediate release of CIM followed by NSAIDs was observed. Drug release of the NSAIDs observed Fickian diffusion mechanism, whereas CIM observed non-Fickian diffusion. Therefore, this delivery system is a promising platform to control the delivery of NSAIDs to combat inflammatory diseases, thereby protecting against possible gastrointestinal side effects that may arise from the overuse of NSAIDs.
“…with the exception of drug carriers characterized by larger surface areas such as pellets and granules in which cases, the release kinetics tend to be significantly more rapid. Besides, drug release from formulations such as ethylcellulose coated microcapsules may also be a function of the capsular wall thickness in addition to the surface area (Grund et al, 2014, Muschert et al, 2009, Rowe et al, 2009, Zhang et al, 2016a, Zhang et al, 2016b).…”
Section: General Properties In Relation To Pharmaceutical and Biomedimentioning
confidence: 99%
“…As an ofloxacin-loaded floating bioadhesive multiparticulate delivery system (Fig. 5(a)), ethylcellulose in the form of Surelease® E-7-19040 combined with Eudragit® NE 30D were used to achieve optimal weight gain for robust pellet core structures and as coating which aided an extended release characteristic (Zhang et al, 2016a, Zhang et al, 2016b). Muschert et al (2009) developed multi-layered pellet delivery systems (Fig.…”
Section: Macro-structured Delivery Systems Fabricated From Ethylcellumentioning
confidence: 99%
“…Ethylcellulose aqueous dispersion NF (Aquacoat®) was employed as an external coat layer and it was discovered that amongst other applied excipients layers, it was dominant for exhibited sustained release characteristics, minimized potential effects of pellet core type and nature of the surrounding bulk fluid.…”
Section: Macro-structured Delivery Systems Fabricated From Ethylcellumentioning
“…were the most used as coating. There are few non-effervescent pellets described in the literature, they can be obtained by producing hollow cores due to solubilisation of a water soluble excipients, such as sugar (NANDE, 2009;ZHANG et al, 2016) and mannitol (LI et al, 2014), by producing a porous matrix due to sublimation of a volatile substance (HWANG et al, 2016) or through CO2 release from the NaHCO3 thermal degradation (VO et al, 2017).…”
Section: Floating or Low-density Systemsmentioning
FORTES, A.C. Application of polyurethane resin from castor oil in controlled release gastroretentive dosage forms. 2017. 85p. Tese (Doutorado)-Faculdade
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.